In today's competitive and value-driven pharmaceutical market, digital health has emerged as a key strategic lever for brand differentiation and overcoming specific revenue challenges. These challenges include the size of the total addressable market, poor medication adherence, and the impact of loss of exclusivity due to patent expiration. However, without a solid business case that clearly outlines measurable commercial impacts, digital health solutions may struggle to secure the necessary internal support and funding.
What you’ll learn:
- How to construct a compelling business case: Demonstrating how digital health solutions can drive value at every stage of the drug lifecycle
- Key components of a strong business case: What to include (and avoid) to build trust across clinical, commercial, and market access teams
- Structuring ROI over time: How to align timelines and expectations with internal decision-makers, especially when early data is limited
- Common misconceptions about demonstrating ROI for digital health: How to address them with clarity and confidence
- Real-world examples of digital health solutions that have delivered commercial success: Outlining the metrics and business models that supported them.
